AMIKACIN;
CAPREOMYCIN;
ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN;
ISONIAZID;
ISONIAZID PLUS RIFAMPICIN;
KANAMYCIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
ANTIBIOTIC SENSITIVITY;
COHORT ANALYSIS;
DRUG RESISTANT TUBERCULOSIS;
HUMAN;
LETTER;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
TREATMENT DURATION;
UNITED STATES;
ANTITUBERCULAR AGENTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, BACTERIAL;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
HUMANS;
ISONIAZID;
MICROBIAL SENSITIVITY TESTS;
MYCOBACTERIUM TUBERCULOSIS;
RIFAMPIN;
TIME FACTORS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
UNITED STATES;
EID: 84862538585PISSN: 10806040EISSN: 10806059Source Type: Journal DOI: 10.3201/eid1807.120261Document Type: Letter
Centers for Disease Control and Prevention, Atlanta (GA): US Department of Health and Human Services; 2009
Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2008. Atlanta (GA): US Department of Health and Human Services; 2009.
Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States
LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis. 2010;14:1226-32.
American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: Treatment of tuberculosis
Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603-62. http://dx.doi.org/10.1164/rccm.167.4.603
Notice to readers: Revised definition of extensively drug-resistant tuberculosis
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 2006;55:1176.
Predictors of failure in timely tuberculosis treatment completion, United States
In press
Mitruka K, Winston CA, Navin TR. Predictors of failure in timely tuberculosis treatment completion, United States. Int J Tuberc Lung Dis. 2012;16. In press.
Completion of tuberculosis therapy for patients reported in the United States in 1993
Bloch AB, Cauthen GM, Simone PM, Kelly GD, Dansbury KG, Castro KG. Completion of tuberculosis therapy for patients reported in the United States in 1993. Int J Tuberc Lung Dis. 1999;3:273-80.
Isoniazidmonoresistant tuberculosis in the United States, 1993 to 2003
Hoopes AJ, Kammerer JS, Harrington TA, Ijaz K, Armstrong LR. Isoniazidmonoresistant tuberculosis in the United States, 1993 to 2003. Arch Intern Med. 2008;168:1984-92. http://dx.doi.org/10.1001/archinte.168.18.1984
